
Portage Biotech Investor Relations Material
Latest events

Q2 2025
25 Nov, 2024

Q1 2025
27 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Portage Biotech Inc
Access all reports
Portage Biotech Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology treatments. The company is focused on advancing first-in-class therapies that target checkpoint resistance pathways, with the goal of achieving durable treatment responses and improving the quality of life for patients with cancer. Portage Biotech's approach aims to address the limitations of current cancer therapies by offering potentially more effective treatment options. The company's research and development efforts are concentrated on novel multi-targeted therapies that can be used both as monotherapies and in combination with other treatments to combat cancer more effectively. The company is headquartered in Westport, Connecticut, and its shares are listed on the Nasdaq.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PRTG
Country
🇺🇸 United States